BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home » Authors » Holland Johnson

Holland Johnson

holland.johnson@clarivate.com
Articles

ARTICLES

Financings roundup: Medidata tests IPO waters with $75.9 million offering

June 26, 2009
By Holland Johnson

Entrepreneurs explore ways to innovate in challenging times

May 14, 2009
By Holland Johnson

St. Pierre: FDA goal is to bring new products to market

May 14, 2009
By Holland Johnson
MINNEAPOLIS – In what the IBF Med-Tech Investing conference held here last week billed as a fireside chat – complete with a virtual log fire on two big screens – Don St. Pierre, associate director for policy and operations at the Center for Devices and Radiologic Health's (CDRH) Office of In Vitro Diagnostic Device Evaluation and Safety (OVID), discussed potential heightened barriers to the use of the 510(k), including the need for more scientific data for this regulatory pathway. (Diagnostics & Imaging Week)
Read More

Panel looks at the difficulties of paying for new innovation

May 13, 2009
By Holland Johnson

St. Pierre: FDA goal is to bring new products to market

May 12, 2009
By Holland Johnson

Entrepreneurs explore ways to innovate in challenging times

May 11, 2009
By Holland Johnson

Investment bankers look at healthcare funding challenges

May 8, 2009
By Holland Johnson
MINNEAPOLIS – It is a challenging time to be out looking for funding if you are involved in the medical technology sector, but companies aren't the only ones having trouble raising money. Venture capitalists are also struggling to put together funding rounds in some instances, particularly trying to raise money from gun shy institutional investors who are the lifeblood of their business. (Medical Device Daily)
Read More

Speaker: past trends boost optimism on med-tech sector

May 7, 2009
By Holland Johnson
MINNEAPOLIS – As the 8th edition of the IBF Med-Tech Investing Conference got under way here yesterday, the tone of the talks was generally upbeat, considering the consistently gloomy state of the economy. (Medical Device Daily)
Read More

Financings roundup: Ardian raises $47M round for new hypertension technology

March 24, 2009
By Holland Johnson
Ardian (Palo Alto, California), a privately held developer of the Symplicity, a catheter-based medical device to treat hypertension, reported receiving one of the largest financing rounds in the medical technology sector in the last six months, with a raise of $47 million. (Medical Device Daily)
Read More

Deals roundup: BC to buy Olympus lab-based diagnostics unit for $800M

March 5, 2009
By Holland Johnson
View All Articles by Holland Johnson

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 12, 2025.
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 10, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing